Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 457 clinical trials
Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression

This is a randomized, double-blind, placebo-controlled, multicenter, Phase 3 study to evaluate if high-dose Octagam 10% therapy can stabilize or improve clinical status in patients with severe Coronavirus disease

covid-19
throat
fraction of inspired oxygen (fio2)
pao2/fio2 ratio
FIO2
  • 0 views
  • 19 Feb, 2024
  • 5 locations
A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19

This randomized, open-label, prospective, parallel-group controlled clinical study that aims to explore the natural history of COVID-19 illness and the safety of KB109, a novel glycan, plus SSC versus SSC alone and measures of health in outpatients with mild-to-moderate COVID-19.

  • 0 views
  • 19 Feb, 2024
  • 8 locations
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate …

covid-19
blood test
  • 0 views
  • 19 Feb, 2024
  • 11 locations
Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection

This is a multicenter, Phase 2 study, to assess the efficacy of the treatment with convalescent plasma in patients with severe COVID-19 infection.

covid-19
x-rays
acute respiratory syndrome (sars)
respiratory failure
oximetry
  • 0 views
  • 19 Feb, 2024
  • 6 locations
Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19

Double blind, placebo controlled, randomized clinical trial to evaluate the efficacy of ivermectin in preventing progression of disease in adult patients with early stages of COVID-19

covid-19
acute respiratory syndrome (sars)
SARS
ivermectin
  • 0 views
  • 19 Feb, 2024
  • 1 location
Safety Tolerability and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198

This is a phase 1 study in which healthy adult volunteers will receive BRII-198 or placebo and will be assessed for safety, tolerability, and pharmacokinetics.

monoclonal antibodies
body mass index
  • 0 views
  • 19 Feb, 2024
  • 1 location
Efficacy and Safety of Mucoadhesive Sustained Release Mucodentol in Comparison With Hydroxychloroquine to Prevent COVID-19

180 people from the medical staff and high-risk people in Baqiyatallah Hospital, who are in close contact with patients, will enter the study. Participants will be divided into two intervention groups and one control group. The control group will use the full protective equipment assigned to the treatment staff. In …

covid-19
hydroxychloroquine
throat
  • 0 views
  • 19 Feb, 2024
  • 1 location
Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

In vitro study have shown its activity against SARS-CoV-2, however its clinical effect on patients with COVID-19 never been tested. In this RCT we would like to evaluate the effect of Ivermectin on reduction of viral shedding among mild to moderate COVID-19 patients, and in shortening the symptom resolution time.

covid-19
ivermectin
acute respiratory syndrome (sars)
SARS
viral shedding
  • 0 views
  • 19 Feb, 2024
  • 1 location
Safety Tolerability and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196

This is a phase 1 study in which healthy adult volunteers will receive BRII-196 or placebo and will be assessed for safety, tolerability, and pharmacokinetics.

monoclonal antibodies
body mass index
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study of the Efficacy and Safety of Intravenous Pamrevlumab in Hospitalized Patients With Acute COVID-19 Disease

This is a Phase 2 trial to evaluate the efficacy and safety of intravenous (IV) infusions of pamrevlumab as compared to placebo in hospitalized subjects with acute COVID-19 disease.

covid-19
acute respiratory syndrome (sars)
pneumonia
oximetry
capillary oxygen saturation
  • 0 views
  • 19 Feb, 2024
  • 1 location